A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

A Study to Evaluate the Safety and Immunogenicity of
an Adjuvanted RSV Vaccine in Healthy Older Adults. Final Report: A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding, First-in-Human Study to Describe the Safety,Tolerability, and Immunogenicity of an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine in Healthy
Older Adults.

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06928316
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
C3671002
Open Plain Language Summary Result:Click here